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When our knowledge of a field accumulates to a certain level, we are bound to see the rise of one or more great scientists. They will 
make a series of grand discoveries/breakthroughs and push the discipline into an ‘age of grand discoveries’. Mathematics, geography, 
physics and chemistry have all experienced their ages of grand discoveries; and in life sciences, the age of grand discoveries has ap-
peared countless times since the 16th century. Thanks to the ever-changing development of molecular biology over the past 50 years, 
contemporary life science is once again approaching its breaking point and the trigger for this is most likely to be ‘lifeomics’. At the 
end of the 20th century, genomics wrote out the ‘script of life’; proteomics decoded the script; and RNAomics, glycomics and 
metabolomics came into bloom. These ‘omics’, with their unique epistemology and methodology, quickly became the thrust of life 
sciences, pushing the discipline to new high. Lifeomics, which encompasses all omics, has taken shape and is now signalling the 
dawn of a new era, the age of grand discoveries. 
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Natural science is the “art” of discovery, and discovery is 
the cornerstone of natural science. Discovery, which ex-
plores the known and the unknown, is a mastery that re-
quires accumulated knowledge and original innovation. A 
detailed look at the history of science reveals numerous 
examples of ‘spurring with long accumulation’: when our 
understanding of a field accumulates to a certain level, we 
are bound to see the rise of one or more groundbreaking 
scientists. These great scientists will trigger a flood of dis-
coveries, break the shackles of time and advance our under-
standing to new high. The result is an explosive growth in 
one or more related disciplines, bringing new ideas and 
fundamental changes and this is when a new era begins, i.e., 
the age of grand discoveries. Thanks to the rapid develop-
ment of molecular biology over the past 50 years, especially 
in the area of omics over the past 20 years, contemporary 
life science is once again approaching its breaking point and 
the trigger for this is most likely to be ‘lifeomics’ (i.e., ge-
nomics, RNAomics, proteomics, etc.). 
1  The age of grand discoveries in science 
Our understanding and learning of natural sciences begins 
with mathematics. Modern science is precisely the pursuit 
of mathematical laws governing nature. Indeed, many sci-
entific breakthroughs were made through the development 
of mathematics. The Pythagoreans of ancient Greece made 
remarkable contributions that triggered the first age of grand 
discoveries in mathematics. They were the earliest people to 
demonstrate the Pythagorean Theorem and propose the 
concepts of odd, even, prime, amicable and whole numbers. 
The Pythagoreans considered arithmetic as an ‘absolute and 
discrete quantity’, music as a ‘relative and discrete quantity’, 
geometry as a ‘static and continuous quantity’, and astron-
omy as a ‘dynamic and continuous quantity’. They estab-
lished the doctrine that ‘mathematics is the basis of every-
thing’. Because of this doctrine, the Greek philosopher Plato 
wrote above his academy entrance, “let no one ignorant of 
geometry enter here.” He viewed mathematics as an indis-
pensable tool for understanding the structure of the universe. 
202 He F C.   Sci China Life Sci   March (2013) Vol.56 No.3 
Thereon, the development of mathematics became the cor-
nerstone of all disciplines that followed. 
The age of grand discoveries in geography lasted a mere 
40 years, but its impact on the world was felt for hundreds 
of years. At the turn of the 16th century, the geocentric the-
ory and the European compass took us to places and routes 
unknown to civilization. In 1485, Christopher Columbus 
discovered North America; in 1497, Vasco da Gama dis-
covered the Indian Ocean and India; in 1498, Christopher 
Columbus discovered South America; in 1519, Ferdinand 
Magellan sailed to the southern tip of South America and 
discovered a strait that joins the Atlantic and Pacific Oceans; 
and in 1521, Magellan crossed the strait and discovered the 
Pacific Ocean, marking a major turning point in modern 
Western civilization [1]. These geographical explorations 
brought forth a spread of revolutionary ideas and commer-
cial activities, greatly expanding the universe as conceived 
by Aristotle and Ptolemy. The change prompted many in-
tellectuals in Europe to question the authority of the Church, 
challenging their age-old beliefs and views about the world. 
The resulting awakening opened the door to critical thinking 
and promoted innovation in the revolution of science. 
Chemistry experienced immense growth during its 
founding period thanks to the discovery of gases and ele-
ments in the 18th century. In 1756, Joseph Black discovered 
carbon dioxide; in 1760, Daniel Rutherford discovered ni-
trogen; in 1766, Henry Cavendish discovered hydrogen; and 
in 1774, Joseph Priestley discovered oxygen [1]. As a result 
of these discoveries, in 1789, Antoine-Laurent Lavoisier 
provided a more scientific explanation for combustion—in 
terms of oxidation—to challenge the then prevailing phlo-
giston theory. After extensive research, Lavoisier wrote the 
book Traité Élémentaire de Chimie (Elementary Treatise on 
Chemistry) and presented his definition of an element. Be-
cause of his work, more than half of all elements that exist 
in our universe for billions of years were found in the dec-
ades that followed (Table 1). It was nothing more than a 
glory for human beings. In 1869, Dmitri Mendeleev orga-
nized the then known 63 elements into groups with similar 
properties. He recognized that there was a pattern in the 
way elements behave and created the first periodic table. 
The examples above illustrate how some of the greatest 
discoveries in chemistry were gestated through accumula-
tion or evolution of knowledge and finally born from their 
revolution.  
So far, we have only mentioned disciplines whose ages 
of grand discoveries took place at the early stage of devel-
opment. People might ask, “can a mature discipline enter 
the age of grand discoveries once again?” The answer is yes, 
and astronomy and physics are two great examples. 
Astronomy and mathematics are the oldest of the natural 
sciences. These disciplines spearheaded the development of 
science during the Age of Enlightenment. The emergence of 
heliocentric theory and telescope technologies at the turn of 
the 17th century triggered the first age of grand discoveries 
in astronomy. In 1572, Tycho Brahe detected a stellar ex-
plosion in the constellation Cassiopeia. He made detailed 
observations and records for 16 months before reporting the 
discovery of a supernova. In 1577, Tycho studied a bright 
comet for 74 days and, based on his observations, deduced 
that our planet was orbiting the Sun and that comets were 
not atmospheric phenomena [1]. In 1576, Tycho received 
the financial support from Frederick II, the then King of 
Denmark, to build an observatory on the island of Hven. 
Since then, Tycho had been studying the movement of stars, 
planets, the Sun and the Moon, day after day, year after year, 
for 21 years. He collected a huge amount of observational 
data before publishing his first comprehensive star cata-
logue, which detailed the position of more than 1000 stars. 
Known as the ‘king among astronomers’, Tycho pushed 
observational astronomy to new high using naked eyes only. 
His celestial positions were amazingly accurate, supersed-
ing those of any predecessor. In 1600, Tycho offered the 
talented Johannes Kepler unrestricted access to his wealth 
of observational data. Based on Tycho’s precise data, Kep-
ler worked out the orbits of the planets and developed his 
three laws of planetary motion. He showed that all planets 
move in ellipses with the Sun at one focus, proving that the 
Copernicus’ heliocentric model was indeed correct. Because 
the planets of our solar system move through space accord-
ing to Kepler’s laws, many people called Kepler the ‘legis-
lator of the heavens’. Even Kepler’s tomb carries an epitaph 
he wrote himself, “I measured the skies, now the shadows I 
measure. Skybound was the mind, earthbound the body 
rests”. Some say it was only because of Tycho’s precise 
observations that Kepler worked out the laws of planetary 
motion. Therefore, for a mature discipline such as astrono-
my to enter the age of grand discoveries again, it must first 
accept a revolutionary hypothesis. Subsequently, discover-
ies made in the new age can be used to support the hypothe-
sis. 
The early 17th century saw the birth of another physicist 
whose achievements equalled those of Kepler—Galileo 
Galilei. He is considered by many to be the ‘father of sci-
ence’, as well as the creator of modern experimental science. 
In 1604, Galileo derived the first (uniform velocity) and 
second laws of motion (uniform acceleration); in 1609, he 
discovered uneven terrains on the moon and created a topo-
logical map of the lunar surface using a telescope he made 
for observing celestial bodies [1]; Galileo discovered Jupi-
ter’s four satellites, providing supportive evidence for Co-
pernicus’ theory; two years later, Galileo discovered sun-
spots, solar rotation and the planetary phases of Venus and 
Mercury. The chain of discoveries initiated a new age of 
grand discovery for astronomy. Galileo established a re-
search approach that integrates experimental measurements 
with the- oretical analyses through observations. His famous 
quote, “measure what can be measured, and make measura-   
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Table 1  Chemical elements that were discovered in the 19th century (52 different elements) 
Z Year Chemical element Country Discovered by 
1 1868 He (Helium) France Pierre Janssen 
   UK Named by Lockyer S. N. 
2 1817 Li (Lithium) Sweden Arfwedson J. A. 
3 1808 B (Boron) UK Davy H. 
4 1898 Ne (Neon) Germany Koch Robert 
5 1807 Na (Sodium) Germany Davy H. 
6 1808 Mg (Magnesium) France Davy H. 
7 1825 Al (Aluminium) Denmarl Oeisted H. C. 
8 1823 Si (Silicon) Sweden Bertholius J. J. 
9 1810 Cl (Chlorine) Sweden Scheele C. W. 
   UK Named by Davy H. 
10 1894 Ar (Argon) UK Rayleigh J. W. & Ramsay W. 
11 1807 K (Potassium) UK Davy H. 
12 1808 Ca (Calcium) UK Davy H. 
13 1879 Sc (Scandium) Sweden Nilson L. F. 
14 1831 V (Vanadium) Sweden Sefstrom N. G. 
15 1875 Ga (Gallium) France De Boisbaudran L. 
16 1885 Ge (Germanium) Germany Winkler C. A. 
17 1817 Se (Selenium) Sweden Berzelius J. J. 
18 1824 Br (Bromine) France Balard A. J. 
19 1898 Kr (Krypton) UK Ramsay W. 
   UK Named by Travers M. W. 
20 1860 Rb (Rubidium) France by Bunsen R. 
    Named by Kirchhoff G. R. 
21 1808 Sr (Strontium) UK Davy H. 
22 1801 Nb (Niobium) UK Hatchett C. 
23 1827 Ru (Ruthenium) Russia Klaus K. K. 
24 1803 Rh (Rhodium) UK Wollaston W. H. 
25 1803 Pd (Palladium) UK Wollaston W. H. 
26 1817 Cd (Cadmium) Germany Stromeyer F. 
27 1863 In (Indium) Germany Richter H. T. & Reich F. 
28 1814 I (Iodine) France Courtois B. 
29 1898 Xe (Xenon) UK Ramsay W. 
    Named by Travers M. W. 
30 1860 Cs (Caesium) Germany Bunsen R. & Kirchhoff G. R. 
31 1808 Ba (Barium) UK Davy H. 
32 1839 La (Lanthanum) Sweden Mosander C. G. 
33 1803 Ce (Cerium) Sweden Berzelius J. J. 
   Germany Klaproth M. H. 
   Sweden Hisinger W. 
34 1885 Pr (Praseodymium) Austria Auer von Welsbach C. 
35 1885 Nd (Neodymium) Austria Auer von Welsbach C. 
36 1879 Sm (Samarium) France De Boisbaudran H. L. 
37 1896 Eu (Europium) France Demarcay E. 
38 1880 Gd (Gadolinium) Sweden De Marignac J. G. 
   France First isolated by de Boisbaudran H. L. 
39 1843 Tb (Terbium) Sweden Mosander C. G. 
40 1886 Dy (Dysprosium) France De Boisbaudran H. L. 
41 1879 Ho (Holmium) Sweden Cleve P. T. 
42 1843 Er (Erbium) Sweden Mosander C. G. 
43 1879 Tm (Thulium) Sweden Cleve P. T. 
44 1878 Yb (Ytterbium) Switzerland Marignac J. G. 
45 1802 Ta (Tantalum) Sweden Ekaberg A. G. 
46 1803 Os (Osmium) UK Tennant S. et al. 
47 1803 Ir (Iridium) UK Tennant S. et al. 
48 1861 Tl (Thallium) UK Crookes W. 
49 1898 Po (Polonium) France Curie P. & Curie M. S. 
50 1898 Ra (Radium) France Curie P. & Curie M. S. 
51 1899 Ac (Actinium) France Debierne A. L. 
52 1828 Th (Thorium) Sweden Berzelius J. J. 
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ble what cannot be measured”, has inspired many experi-
mentalists for dozens of generations. Galileo established a 
new direction for theoretical physics on the basis of exper-
imental science. Because of him, we have boundless free-
dom to explore the physical world. 
Discoveries made by Kepler and Galileo ushered in a 
new era—the Newtonian era. Issac Newton invented the 
binomial theorem and differential calculus in mathematics, 
established the law of universal gravitation in astronomy, 
laid down the three laws of motion in physics, and discov-
ered the visible spectrum and reflecting telescope in optics. 
Having made these great achievements, Newton in 1686 
published Philosophiae Naturalis Principia Mathematica 
(Mathematical Principles of Natural Philosophy) [1], a 
masterpiece that epitomizes his work on mechanics and 
gravitation. Lord Newton once said, “if I have seen further 
it is by standing on the shoulders of giants”. Many people 
take these as Newton’s humble words, but if we review 
them carefully, we realise the true meaning of his words. It 
was through Tycho’s precise data that Kepler derived the 
laws of planetary motion; it was through large amounts of 
experimental work that Galileo derived the first and second 
laws of motion; and it was through the integration of related 
laws in physics and astronomy that we arrived at the epito-
me of Newtonian mechanics. In other words, Newton un-
derstood that it was only through standing on the shoulders 
of giants like Tycho, Kepler and Galileo that he achieved so 
much in his lifetime. In the same sense, it was through large 
amounts of observation, accumulation of experimental data, 
and grand discoveries of laws that we produced these giants. 
In the late 19th century, the theoretic building of Newton 
epitomized the studies of acoustics, optics, electromag-
netism and thermodynamics. His ‘universal’ laws worked 
on all matter, from the smallest of microscopic particles to 
the largest of heavenly bodies. People felt there were little 
room for expansion in the development of science. However, 
there were two ‘dark clouds’ hanging over classical physics: 
the Michelson-Morley experiment and blackbody radiation. 
Thanks to these two phenomena, relativity and quantum 
theory were developed to replace Newtonian mechanics as 
the more generalized theories of the physical world. In ad-
dition, a new ‘hypothesis-driven’ research approach, as op-
posed to the conventional “discovery-driven” research ap-
proach, emerged. Therefore, can we derive all theories from 
hypotheses? The answer is not always, even for highly the-
oretical disciplines like astronomy and physics where theo-
ries are typically derived from observations. Some of these 
observations rely on hypotheses, while others have com-
pletely no theoretical bases. For example, discoveries de-
rived from aforementioned geocentric and heliocentric the-
ories were driven by and proven from hypotheses. However, 
the discovery of Kepler’s three laws and Galileo’s two laws 
did not rely on any hypothesis. They were purely based on 
scientific observations and vast amounts of scientific data. 
Even in the case of relativity, which involves a lot of 
thought experiments, the main assumptions were based on 
results from the Michelson-Morley experiment. In reality, 
the hypothesis-driven approach is just as important as the 
discovery-driven approach when it comes to developing 
science and technology. Like what the pioneer Galileo once 
said, to “measure what can be measured, and make meas-
urable what cannot be measured.” This should be the basic 
principle of modern science, especially experimental sci-
ence. 
In light of these examples, we see that only through ac-
cumulation of knowledge can we get results. Discovery is a 
process led by theory and driven by technology. Without 
discovery, there will be no scientific revolution. 
2  The age of grand discoveries in life sciences 
Life science is an ancient but exciting discipline where new 
discoveries are being made everyday. Its golden era, as a 
whole, spans from 500 years ago to the present. 
Modern life science was triggered by great discoveries in 
biology during the 16th and 17th centuries. In 1543, the 
Flemish anatomist Andreas Vesalius gained a thorough un-
derstanding of the human anatomy through dissecting ani-
mals and human cadavers. His book De Humani Corporis 
Fabrica (On the Human Body Structure) gave detailed de-
scriptions of the human body, including its skeletal system, 
muscular system, vascular system, nervous system, diges-
tive organs, internal organs and sensory organs. The dis-
covery was a major triumph over ignorance and Christian 
supremacy. The book De Humani Corporis Fabrica not 
only opened a new chapter in the study of life sciences, but 
also laid the cornerstone of modern medicine. In 1616, Wil-
liam Harvey described the structure of the human heart and 
established the theory of blood circulation. In the 1660s, 
Marcello Malpighi discovered that the respiratory system of 
small animals has a higher surface-to-volume ratio than that 
of higher animals. In 1665, Robert Hooke published Mi-
crographia and coined the term ‘cell’ to describe the basic 
unit of life. In 1683, Antonie van Leeuwenhoek discovered 
bacteria. In 1688, he gave detailed description of red blood 
cells. In light of these examples, we can see that discoveries 
in biology have improved our understanding of the micro-
scopic world.  
The 17th century was an age of grand discoveries for the 
study of biological species. In 335 BC, Aristotle conducted 
research and provided detailed description for over 500 
animal species. He coined the term “animal” and wrote the 
first book on zoology, which dictated the academic field for 
over a millennium. In the 1600s, the number of plant spe-
cies known to science was approximately 6000. Then in the 
17th century, scientists discovered 12000 new plant species 
[1], twice the total number found over the last 2000 years. 
They also found quite a number of new animal species, so 
evidently the period was an age of grand discoveries for the 
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study of biological species. 
Owing to the large number of new species being found, 
there was a growing need of a self-consistent and rational 
classification system. In 1735, Carl Linnaeus published 
Systema Naturae (Natural System) and proposed a new sys-
tem for classifying plants according to their reproductive 
organs. Although subconsciously Linnaeus appeared to go 
against evolutionary views, his classification system ended 
up pushing new ideas forward. From 1749 to 1788, 
Georges-Louis Leclerc de Buffon published the mul-
ti-volume Histoire Naturelle (Natural History) and pro-
posed the radical view that similar organisms may have a 
common ancestor. He was the first scholar to treat the 
origin-of-species problem in a scientific spirit. In 1785, 
James Hutton published his theory on sedimentary rocks 
and biological fossils. Subsequently, the study of fossils 
became a scientific discipline and an important basis for 
understanding biological systems, especially prehistoric 
systems. In 1801, Jean-Baptiste Lamarck published Système 
des Animaux sans Vertebres (System for Invertebrates) and 
proposed the first truly cohesive theory of evolution. In 
1809, he published Philosophie zoologique (Zoological 
Philosophy), which outlined his concept of Lamarckism and 
coined the term ‘biology’ for the first time [1]. In 1831, 
Charles Darwin began his five-year voyage around the 
world, investigating geology and making natural history 
collection. After extensive investigations, he established the 
concept of biological evolution. In 1859, Darwin published 
On the Origin of Species [1], grouping various evolutionary 
ideas together into one ambitious but convincing theory. It 
can be said that, without the discovery of biological species 
and Darwin’s expedition around the world, we would not 
have the theory of evolution as we know it today. 
The advent of cell theory in the 19th century triggered a 
new area in modern medicine, known as experimental med-
icine. In 1831, the Scottish botanist Robert Brown discov-
ered the nucleus. In 1838, Matthias Jakob Schleiden pub-
lished a paper titled Beiträge zur Phytogenesis (Contribu-
tions to Phytogenesis), where he stated that “all plants, no 
matter how complex, are composed of cells” [1]. In 1839, 
Theodor Schwann published a paper titled Microscopic In-
vestigations on the Accordance in the Structure and Growth 
of Plants and Animals, where he concluded that “all living 
things are composed of cells”. The theory broke the bound-
ary between animals and plants. In 1858, Rudolf Virchow 
published Cellular Pathology, where he pointed out that “all 
cells come from other cells” and that “all diseases involve 
changes in normal cells”. In 1875, Eduard Adolf Strasburg-
er published Zellbildung und Zelltheilung (Cell Formation 
and Cell Division), where he pointed out that “all cells 
come from pre-existing cells” and that “all nuclei come 
from other nuclei”. From then on, the cell theory was no 
longer a hypothesis. It was the guiding force of life scienc-
es. 
As microscope technology matured in the second half of 
the 19th century, life science ushered in the era of microor-
ganisms (Table 2). It was a revolutionary period for micro-
biology research, one that was comparable to the theory of 
evolution. In 1856, Louis Pasteur discovered that “fermen-
tation is caused by the growth of microorganisms”. In 1859, 
he disproved the theory of spontaneous generation. From 
1860 to 1880, Pasteur made huge contributions to wine 
pasteurization, silkworm diseases and infectious diseases 
just by one word “microorganism”. He proposed the mech-
anism by which disease was transmitted. From 1870 to 1890, 
Robert Koch developed new theories and techniques in 
bacteriology (e.g., preparing pure culture and staining). He 
proposed and validated the idea that “an organism can be 
isolated in every case of a disease”. He also formulated 
Koch’s postulates, which say that, to establish that an or-
ganism is the cause of a disease: it must be found in all cas-
es of the disease examined; it must be prepared and main-
tained in a pure culture; it must be capable of producing the 
original infection; and it must be retrievable from an inocu-
lated animal and cultured again. Up to date, Koch’s postu-
lates remain the iron laws and gold standards of pathology. 
In 1890, Ilya Ilyich Mechnikov discovered phagocytes and 
phagocytosis, as well as proposed the cellular theory of 
immunity. In 1890, Emil Adolf von Behring discovered a 
serum therapy against diphtheria and tetanus, as well as 
proposed the concept of humoral immunity. These discov-
eries led human beings landing the absolutely new invisible 
world which species number could be comparable with 
those of the traditional, visible worlds of animals and plants, 
defended human rationality against ignorance and Christian 
supremacy, and triggered a revolution in modern medicine, 
known as the antibiotic revolution. 
The 20th century has been described as the century of the 
gene [2]. The development of genetics happened so quickly, 
like a fairy tale in life sciences. In 1900, Hugo de Vries, 
Karl Correns and Erich von Tschermak independently re-
discovered Mendel’s genetic laws. From 1910 to 1930, 
Thomas Hunt Morgan discovered the idea of genetic link-
age and produced the first linkage map of the fruit fly Dro-
sophila. In his books The Physical Basis of Heredity and the 
Theory of the Gene, he provided the first working theory of 
heredity. In 1928, Frederick Griffith [1] discovered a trans-
forming factor in Streptococcus pneumoniae. In 1944, Os-
wald Avery [1] used biochemical methods to confirm that 
the transforming factor was, in fact, DNA. In 1937, the Eu-
ropean pioneer of structural biology William Astbury pro-
posed a structural model for DNA. He took X-ray diffrac-
tion photographs of DNA, showing that its structure is 
strong, rigid and fibrous. In 1951, Maurice Wilkins and 
Rosalind Franklin [1] obtained high-quality X-ray diffrac-
tion photographs of DNA, indicating that its structure is 
most likely to be a right-handed double helix. In 1952, Al-
fred Hershey and Martha Chase used isotope labelling 
method to prove that the genetic material of bacteriophages 
is DNA, not protein. In the same year, Erwin Chargaff [1]    
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Table 2  Discovery Timeline of pathogenic microorganisms 
Year Pathogen Disease caused Origin Discovered by 
1877 Bacillus anthracis  Anthrax Germany Robert Koch  
1878 Staphylococcus  Pyogenesis Germany Robert Koch  
1879 Mycobacterium leprae  Leprosy Sweden Hansen Armaner  
1879 Neisseria gonorrhoeae Gonorrhoea Germany Neisser A. L. S.  
1880 Staphylococcus aureus  Toxic shock syndrome Scotland Alexander Ogston 
1880 Salmonella typhi Typhoid Germany Eberth C. J.  
1881 Streptococcus  Pyogenesis Scotland Ogston A. 
1882 Mycobacterium tuberculosis  Tuberculosis Germany Robert Koch 
1884 Corynebacterium diphtheriae  Diphtheria Germany  Edwin Klebs & Friedrich Loffler 
1884 Vibrio cholerae Cholera Germany Robert Koch  
1884 Clostridium tetani Tetanus Germany Nicolaier A. 
1885 Escherichia coli Diarrhoea Germany Ehrlich Paul  
1886 Streptococcus pneumoniae Pneumonia Germany Fraenkel Karl & Louis Pasteur  
1887 Neisseria meningitides  Epidemic cerebrospinal meningitis Germany Weickselbaum Antou  
1888 Salmonella enteritidis Food poisoning USA Gaertner A. A. H.  
1892 Clostridium perfringens Gas gangrene USA Welch W. H.  
1892 Haemophilus influenzae Meningitis and pneumonia Germany Pfeffer Wilhelm  
1894 Yersinia pestis  Plague Germany 
Independently discovered by Kita-
sato S. & Yersin A. J. E. 
1896 Clostridium botulinum Botulism Belgium van Ermengem E. M. P. 
1896 Salmonella paratyphi Paratyphoid France Achard Charles  
1898 Shigella dysenteriae  Dysentery Japan Shiga K. 
1911 Treponema pallidum Syphilis Japan Hideyo Noguchi  
1906 Bordetella pertussis Pertussis France Bordet J. & Gengou O. 
1909 Bartonella bacilliformis Bartonella disease South America Albert Barton 
1973 Rotavirus Infant diarrhoea Australia Bishop R. F. 
1975 Hepatitis A virus Hepatitis A Germany Stephen M. Feinstone 
1976 Ebola virus Ebola hemorrhagic fever Africa Bowone & Pattyn 
1977 Hantaan virus  Hemorrhagic fever with renal syndrome Korea Lee Ho-wang 




1978 Hepatitis D virus (HDV) Hepatitis D Italy Mario Rizzetto 
1981 Human T-lymphotropic virus 1 (HTLV-1)  T- cell lymphoma, leukaemia USA Bernard Poiesz & Francis Ruscetti 
1982 E. coli. O157, H7 Hemorrhagic colitis USA Riley 
1982 Human T-lymphotropic virus 2 (HTLV-2)  Hairy cell leukaemia Japan Kalyanaraman V. S. 
1982 Borrelia burgdorferi  Lyme disease USA Burdorfer 
1982 Enrterocytozoon bieneusi  Intractable diarrhoea USA Gourley 
1983 Human immunodificiency virus (HIV)  AIDS USA & France Robert Gallo & Luc Montagnier  
1983 Helicobacter pylori  Chronic gastritis, peptic ulcer Australia Barry J. Marshall & Warren J. Robin 
1986 Human herpesvirus 6 (HHV-6)  Early childhood roseola USA Robert C. Gallo  
1983 Hepatitis E virus (HEV)  Hepatitis E Russia Balayan 
1989 Hepatitis C virus (HCV)  Hepatitis C USA 
Michael  
Houghton 
1989 Ehrlichia chafeensis Human ehrlichiosis USA Burt E. Anderson 
1990 Human herpesvirus 7 (HHV-7)  Heat rash, CNS infection USA Niza Frekel 
1991 Gunarito virus Venezuelan hemorrhagic fever Venezuela Salas R. 
1991 Encephalitozoon hellem Meningitis, diffuse lung diseases USA Didier E. S. 
1991 A new species of Babesia  Atypical babesiosis USA Quick R. E. 
1992 Vibrio cholerae  Cholera Asia Filippo Pacini 
1993 Sin Nombre virus Adult respiratory distress syndrome USA Terry Yates 
1994 Sibia virus Brazilian hemorrhagic fever Brazil Barry M. 
1995 Human herpevirus 8 (HHV-8)  AIDS-related Kaposi’s sarcoma USA Enrique A. Mesri  
1995 Hepatitis G virus (HGV)  Hepatitis D USA Simons J. N.  
1996 Prion  New Creutzfeldt–Jakob disease USA Stanley B. P. Prusiner 
1997 Transfusion Transmitted virus (TTV)  Post-transfusion hepatitis Japan Nishizawa T. 
1997 Avian influenza virus (H5N1)  Influenza Hong Kong de Jong 
1998 West Nile virus Nile fever Uganda Smithburn K. C. 
1999 Nipah virus  Encephalitis Malaysia Chua K. B. 
2003 SARS-CoV  Sever acute respiratory syndrome China  
2003 H9N2 Influenza China  
2005 Human bocavirus  Pneumonia Sweden Allander  
2010 
Severe fever with thrombocytopenia syn-
drome bunyavirus 
Fever with thrombocytopenia syndrome China Xuejie Yu 
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showed that DNA has percentage base pair equality 
(%A=%T and %G=%C). Based on the finding, James Wat-
son and Francis Crick [3] discovered the DNA double helix 
in 1953. They suggested that the specific pairing of bases 
may be the replicate mechanism for genetic materials, and 
that the linear sequence of bases may be the code for carry- 
ing genetic information. These revolutionary conjectures 
represent the essence of the DNA double helix. They have 
made a huge splash in life sciences and took the study of 
molecular biology to new high. In addition, they have un-
covered secrets of the biological world and made genetic 
engineering one of the most successful scientific disciplines. 
The 20th century was, without a doubt, the golden era of 
life sciences, especially the age of grand discoveries. 
In 1955, Severo Ochoa demonstrated the first synthesis 
of RNA. In 1957 Arthur Kornberg isolated the first DNA 
polymerase and synthesized the first artificial DNA. The 
finding played a key supportive role in the explanation of 
the genetic code (Nobelprize.org). In 1955, Frederick Sang-
er [4] determined the amino acid sequence of bovine insulin. 
In 1958, John Kendrew and co-workers [5] determined the 
three-dimensional structure of myoglobin; and Francis 
Crick [6] published the groundbreaking paper On Protein 
Synthesis where he proposed his ‘sequence hypothesis’, 
discussing the relation between the sequence of bases in 
DNA and the sequence of amino acids in proteins, as well 
as the ‘central dogma’ (from DNA to RNA to protein). In 
1960, François Jacob and co-workers [7] put forward the 
concepts of mRNA and ‘operon’, detailing the regulatory 
mechanisms that underlie genetic information transfer and 
protein synthesis. In 1961, Marshall Nirenberg and Heinrich 
Matthaei [8] cracked the first codon of the genetic code. In 
1970, David Baltimore [9], Howard Temin and Satoshi Mi-
zutani [10] discovered the reverse transcriptase and ex-
panded the ‘central dogma’, with molecular biology being 
well-established. 
Molecular biology was largely inspired by the reduction-
ist approach of the 1970s, which proved to be extremely 
successful and helped to unravel many of the basic molecu-
lar and cellular processes. Two groups, one led by Stuart 
Linn and Werner Arber [11] and the other led by Hamilton 
Smith and Kent Wilcox [12], independently discovered two 
useful ‘tools’ for cutting and ligating DNA: the restriction 
enzyme and the modification enzyme. In 1970, Daniel Na-
thans used these enzymes to demonstrate the cleavage of 
DNA in vitro. In 1971, Paul Berg used these enzymes to 
create the first recombinant DNA. In 1976, Yuet Wai Kan 
reported the first case of DNA diagnosis in monogenic dis-
eases. In 1977, John Michael Bishop [13] discovered the 
oncogene src. In 1975, Frederick Sanger and co-workers 
[14] discovered a DNA sequencing method and used it to 
decode the whole genome of bacteriophage φX174 two 
years later. In 1978 and 1981, Sidney Altman and Thomas 
Cech independently discovered the catalytic abilities of 
RNA. In 1979, David Goeddel successfully used genetic 
engineering to coax bacteria into mass-producing insulin. In 
1982, Richard Palmiter and Ralph Brinster produced trans-
genic mice, supermice (that express a growth hormone). In 
1985, Kary Mullis and her team [15] developed PCR tech-
nology for amplifying DNA in vitro. The genetic techniques 
have now become a series of indispensable magic tools in 
gene sequencing, genetic recombination, DNA diagnosis, 
genetic engineering, gene transfer and gene amplification. 
Evidently, there had been many continuous and overlap-
ping periods of profound discoveries in the history of con-
temporary life sciences. At every stage of the game, there 
would be one or more leading scientists showing great fore-
sights, turning things around and opening up new avenues 
of research. These great scientists could pierce through the 
dark sky and guide the discipline forward into a new age of 
grand discoveries. 
3  The age of ‘omics’ 
Life forms are the most complex physical systems known 
thus far. Take the human body as an example. From a re-
ductionist point of view, as we move from organs to tissues 
and from cells to molecules, our research subject gets di-
vided into tens or millions individual pieces. Moreover, the 
number of interactions among these individual pieces grows 
exponentially. From a systems theory point of view, we 
need to study not only the multi-level dynamical changes of 
the human biology, but also the complex physical and 
chemical factors of the human environment, the numerous 
symbiotic microbes of the human ecology, and the various 
psychosocial factors of the human society. Our awareness 
of life is like Zeno’s circle: when our circle of knowledge 
becomes greater, our contact with the unknown world also 
becomes greater. Life may look like a magnificent and po-
etic painting in the eyes of ordinary people. Under the mi-
croscope, however, this painting is nothing but pixels, lines 
and blocks of various shades and colours. In this new age of 
life sciences, scientists are puzzling over how to connect 
dots, lines, planes and solids to make something artistic, 
something that is neither The Blind Men and the Elephant 
nor Giuseppe Arcimboldo’s Vertumnus (Figure 1). Lifeom-
ics is like a Russian doll. Just when you think you under-
stand the situation, another mystery of life emerges. The 
reductionist approach seeks to understand living systems 
through the study of their constituent parts—from total 
syntheses to regulatory mechanisms of various biomacro-
molecules. By taking the reductionist approach to the ex-
treme, we can get to the bottom of the problem, turn it into a 
theory and make the most of our time. The holistic approach 
seeks to integrate all constituents into one single system, 
which could turn something simple into something extraor-
dinary. Only a ‘grand master’ who understands the magic of 
this approach can push the discipline to new high. The re-
ductionist approach begins with ‘ome’ and ends with  
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Figure 1  Giuseppe Arcimboldo’s Vertumnus. 
‘o,m,e’ (‘O’, ‘m’ and ‘e’ are respectively to ‘ome’ what 
‘subset’ is to ‘set’ in mathematics.), whereas the holistic 
approach begins with ‘o,m,e’ and ends with ‘ome’. Ge-
nomics, RNAomics, proteomics and metabolomics are ex-
amples of the latter. This is why lifeomics, which uses 
unique epistemology and methodology, quickly became the 
thrust of life sciences. 
The development of omics has led to many great discov- 
eries in life sciences since the late 20th century. In 1953, 
Watson and Crick proposed the double helix structure of 
DNA and said, “the precise sequence of the bases is the 
code which carries genetic information”. In 1958, Sanger 
from the same laboratory established the method for deter-
mining amino acid sequences of protein (http://www.no- 
belprize.org/nobel_prizes/chemistry/laureates/1958/sanger.h
tml). In the 1970’s, he established the method for analysing  
DNA sequences [16]. Because of these two achievements, 
Sanger won the Nobel Prize in Chemistry twice. As the king 
of DNA sequencing, Sanger turned our dreams of reading 
and writing genetic information into a reality. He made 
DNA sequencing a part of life. Through DNA sequencing, 
scientists could integrate biotechnology with information 
technology. In 1986, the first generation of fluores-
cence-based DNA sequencers with automated analysis was 
born. Since then, our DNA sequencing capacity has been 
growing exponentially. Our current daily data output is in 
the Gb range [17], a rate that could rival Moore's Law. Pro-
tein sequencing technologies based on mass spectrometry 
represent another force to be reckoned with. Biological 
mass spectrometry, for example, was awarded the Nobel 
Prize in Chemistry in 2002. At that time, scientists could 
only identify several hundreds of proteins in a given sample. 
Today, biological mass spectrometry could identify several 
thousands of proteins in a single sample, which is about the 
size of a transcriptome. These high-throughput sequencing 
technologies are set to open up new avenues of research and 
trigger an age of grand discoveries in lifeomics. 
The US government launched an international scientific 
research project, dubbed the Human Genome Project (HGP), 
four years after the birth of the first DNA sequencer [18]. 
Since then, countries like Germany, Japan, UK, France and 
China have joined the project. When the project first began, 
there were only 100000 bases pairs in all of the human 
genes known. Ten years later, scientists have not only se-
quenced the 3 billion base pairs that make up the human 
genome, but also the genomes of Saccharomyces (budding 
yeast), Escherichia coli, Mycobacterium tuberculosis, 
Treponema pallidum, Nematoda (nematode), Drosophila 
(fruit fly), Arabidopsis thaliana (mustard plant), Oryza sa-
tiva (rice), Mus musculus (mouse), Plasmodium, Anopheles 
(mosquito), as well as several other important pathogens 
and model organisms. The project has triggered a great 
number of follow-up projects, for example, the International 
HapMap Project in 2002, the 1000 Genome Project in 2008, 
the 10000 Microbial Genomes Project in 2009, as well as 
the 1000 Plants and Animals project and the Genome 10K 
project in 2010. A decade has passed since the publication 
of the first human genome (October 2011), but we have 
already resolved the genomes of over 1200 biological spe-
cies. The National Center for Biotechnology Information 
(NCBI) holds 2.08 Pb (1 Pb=1015 b) of genomic data as of 
14 June 2012, 10 billion times the amount when the project 
first started. Chinese scientists, in particular, have contrib-
uted more than 0.64 Pb of data, which accounts for 30% of 
the total. They made outstanding contributions in three par-
ticular areas: genetic information, gene function and medi-
cal genetics. In terms of genetic information, although we 
can only interpret some and not all of the information, the 
genome sequencing has enabled us to read into the evolu-
tionary process that lasted for hundreds of millions of years. 
Having the genetic information (the blueprint of life) of 
thousands of species represents a huge advantage, but this is 
only the tip of the iceberg. We expect to see more discover-
ies not only in the number of species, but also in the realisa-
tion of richer genomes through whole or single-cell genome 
and transcriptome sequencing. These breakthroughs will 
give us the ability to synthesize and create life. In terms of 
gene function, HGP has already identified more than 20000 
protein-coding genes, when scientists only knew a fraction 
of these genes just a century ago. The findings will help 
unveil the mysteries behind the human genome, transcrip-
tome and proteome, as well as make a splash in comparative 
genomics and animal genomics. Studies have shown that 
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less than 3% of the human genome is protein-coding genes. 
Therefore, following the surprising discovery of dark matter 
and dark energy in physics, we might find astonishing ‘dark 
information’ in life sciences. DNA sequencing technology 
is now within reach of ordinary people thanks the rapid rise 
in capacity and the sharp decline in price over the past 20 
year. It has become a common tool in biological research 
and clinical diagnosis. In the area of medical genetics, for 
an example, we could take genome-wide association study 
(GWAS). GWAS has existed only for less than ten years, 
and during this period of time we have studied more than 
700 diseases and discovered more than 5000 dis-
ease-causing genes and susceptibility loci, ten times the 
number found 100 years ago. Although China was a late 
starter in genomics research, the country’s achievements in 
the field are still remarkable (Table 3). This is in line with 
what Watson said ten years ago, “all biology in the future 
will start with the knowledge of genomes and proceed 
hopefully”. 
Genome sequencing is like the winds of a rising storm. 
To better understand the human genome, we must part the 
clouds and swirl things around. In the month that the draft 
of the human genome was published, the launch of the Hu-
man Proteome Organization (HUPO) was announced. In the 
following year, the Human Proteome Project (HPP) was 
initiated. Given the variety of proteins (at least 100 times 
the number of genes), the huge dynamic range of protein 
abundance, the diversity of post-translational modifications, 
the complex issue of space-time specificity and the great 
number of interactions between the proteins, HPP launched 
a series of pilot projects during its initial phase. In 2002, 
HPP launched the Human Liver Proteome Project (HLPP) 
and the Human Plasma Proteome Project (HPPP). After this, 
HPP launched the Human Brain Proteome Project (HBPP), 
Human Kidney and Urine Proteome Project (HKUPP) and 
Human Cardiovascular Initiate (HCVI). It has also launched 
Proteomics Standards Initiative (PSI), Human Antibody 
Initiative (HAI) and Disease Biomarkers Initiative (Table 4). 
In 2005, HPPP generated a core dataset of 3020 proteins, 
the first human body fluid proteome of its kind. In 2010, 
HLPP released a core dataset of 6788 proteins, the first hu-
man organ proteome of its kind [51]. Over half of these 
proteins were identified in the human liver for the first time. 
Moreover, about a quarter of them were newly discovered at 
the protein level. In 2009, Chinese scientists discovered 
over 1000 acetylated proteins by using high-throughput 
protein analysis and studying metabolic enzymes across 
different species [52]. In addition, they identified the role of 
acetylation in the regulation of metabolic enzymes. In 2012, 
Chinese scientists used bacteria, yeast, nematode, fruit fly, 
mouse and human as research subjects and, through 
large-scale quantitative proteomic data analyses, found 
three universal patterns in the overall distribution of protein 
abundance [53]: protein abundance is positively correlated 
with the protein’s origination time or sequence conservation 
during evolution; protein abundance is negatively correlated 
with the protein’s domain number and positively correlated 
with domain coverage in protein structure; and proteins that 
act on material conversion and transportation are more 
abundant than those that act on information modulation. 
The findings demonstrated that the large-scale dataset of 
omics could be the resource for the discovery of the laws of 
life. Other organ/tissue proteome projects have also gener-
ated 1000–3000 proteins. With increasing technological 
capabilities in recent years, biological mass spectrometry 
can now identify 7000–9000 proteins in a cell line sample, 
with gene expression coverage reaching 60%–90%. Re-
search on protein interaction networks has also made amaz-
ing progress. In 2005, two research groups in Germany and 
USA independently established human protein interaction 
networks featuring 3169 pairs and 2,754 pairs of proteins 
[54]; in 2011, China scientists established a human liver 
protein interaction network that encompasses 3484 interac-
tions among 2582 proteins [55]. In the three studies we just 
mentioned, there had only been 54 cases of overlapping 
protein interactions. The number suggests that more than 
90% of protein interaction network is still unknown and 
waiting to be discovered. In 2011, research on human en-
dogenous protein complexes has identified more than 11000 
products of gene expression, which accounts for about 50% 
of the total. In addition, HAI released the 7th version of its 
database, which covers 10118 products of coding genes. In 
2009, OVA1, the first proteomics-discovered cancer bi-
omarker discovered by Daniel Chan and his team received 
approval from the USA Food and Drug Administration 
(FDA) for detecting ovarian cancer (http://www.fda.gov/ 
NewsEvents/Newsroom/Press-An-nouncements/ucm182057
.htm). The event signals the advent of more great discover-
ies and clinical applications in proteomics. 
Genomics and proteomics are the two most active areas 
within the field of lifeomics. After the completion of HGP, 
it was found that protein-coding sequences make up only 
about 2% of the human genome [56]; among the non-coding 
DNA and RNA sequences, about 1/4 are tRNA and rRNA, 
and 3/4 are snRNA, snoRNA, shRNA, microRNA and 
lncRNAs (long non-coding RNAs), which have important 
roles in chromatin remodelling, transcriptional regulation 
and translational regulation [57], affecting biological de-
velopment, cell proliferation, cell differentiation, as well as 
the development of cancer, metabolic diseases and viral 
diseases. Since the advent of ‘RNAomics’ in 2000, more 
than 35000 non-coding RNA have already been discovered 
in mammals. The mutual regulation between DNA, mRNA, 
protein and non-coding RNA has attracted wide attention 
from the community. The technology RNAi won the 2006 
Nobel Prize in Physiology and Medicine only eight years 
after it was discovered. Such case is rare in the Nobel Prize 
history. Coincidentally, systems biologists have taken an 
interest in ‘glycomics’, which studies the structure and 
recognition molecules of oligosaccharides, polysaccharides    
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Table 3  GWAS conducted by Chinese scientists 
Year of publication Disease studied Research group Reference 
2009 Psoriasis Xuejun Zhang et al. [19] 
2009 Systemic lupus erythematosus Xuejun Zhang et al. [20] 
2009 Leprosy Furen Zhang et al. [21] 
2010 Nasopharyngeal cancer Yixin Zeng et al. [22] 
2010 Vitiligo Xuejun Zhang et al. [23] 
2010 Hepatocellular carcinoma Fuchu He & Gangqiao Zhou et al. [24] 
2010 Oesophageal cancer Lidong Wang et al. [25] 
2010 Agronomic traits of indica rice Bin Han et al. [26] 
2010 Polycystic ovary syndrome Zijiang Chen et al. [27] 
2011 Coronary artery disease Qing Wang et al. [28] 
2011 Oesophageal cancer Dongxin Lin et al. [29] 
2011 Atopic dermatitis Xuejun Zhang et al. [30] 
2011 Lung cancer Hongbing Shen et al. [31] 
2011 Graves’ disease Huaidong Song et al. [32] 
2011 Gastric cancer Hongbing Shen et al. [33] 
2011 Schizophrenia Lin He et al. [34] 
2011 Schizophrenia Dai Zhang et al. [35] 
2011 Leprosy Furen Zhang et al. [36] 
2011 Flowering time and grain yield of rice Bing Han et al. [37] 
2011 Pancreatic cancer Dongxin Lin et al. [38] 
2011 Ankylosing spondylitis Jieruo Gu et al. [39] 
2011 IgA nephropathy Xueqing Yu et al. [40] 
2011 Non-obstructive azoospermia Jiahao Sha et al. [41] 
2012 Kawasaki disease Jer Yuarn Wu et al. [42] 
2012 Coronary artery disease Dongfong Gu et al. [43] 
2012 Polycystic ovary syndrome Zijiang Chenet al. [44] 
2012 Thyrotoxic periodic paralysis Annie Wai Chee Kung et al. [45] 
2012 Oesophageal cancer Dongxin Lin et al. [46] 
2012 Prostate cancer Yinghao Sun et al. [47] 
2012 Hepatocellular carcinoma Long Yu et al. [48] 
Table 4  Progress of the Human Proteome Project 
Year of 
initiation 
Sub-project Dataset Release year 
2002 Human Liver Proteome Project ProteomeView, 6847 proteins (6788 [51]) 2010 
2002 Human Plasma Proteome Project Human Plasma PeptideAtlas, 1929 proteins (3020 [49]) 2005 
2003 Human Brain Proteome Project 1832 (human)/792 (mouse) proteins 2010 
2003 Proteomics Standardization Initiative 
Protein information, mzML 
Molecular interaction, PAR/MIAPAR/PSICQUIC 
Protein separation, MIAPE-GEL/MIAPE-CC/MIAPE-CE 
2010 
2005 Human Kidney and Urine Proteome Project 
Human Kidney and Urine Proteome Project, 3679 proteins; the final 
standards for non-protein urine and urine proteome 
2009 
2005 Human Antibody Initiative The 10th edition of database encompasses 14079 coding genes 2012 
2005 Human Disease Glycomics/Proteome Initiative 
Comparison of full-spectrum analysis methods for O-glycosylation; 
full-spectrum analysis of glycoproteins in cancer cells 
2010 
2005 Mouse Model of Human Disease More than 1400 mouse secreted proteins have been identified 2006 
2006 Human Cardiovascular Initiative 
1333 proteins with more than 10000 GO annotations; more than half 
of which are from human data 
2009 
2007 Proteome Biology of Stem Cell Initiative 
Stem cell markers, stem cell signalling pathways and stem cells & 
diseases 
2009 
2009 Disease Biomarkers Initiative Markers for cancer, cardiovascular disease and pulmonary disease 2010 
2010 Model Organism Proteomes Advances in model organisms 2010 
2010 Chromosome-based Human Proteome Project J Proteome Res, Publication Date (Web): January 11, 2013 2013 
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and various sugar chains, as well as ‘metabolomics’, which 
studies the endogenous metabolites and their responses to 
external stimuli. Much progress has been made over the past 
ten years, and these omics are becoming a major force in 
life sciences. 
Like the Chinese saying goes, “when spring comes, all 
flower blossoms”. Different omics have made varying lev-
els of contributions to life sciences. In 2005, HPP initiated 
the Human Disease Glycomics/Proteome Initiative (HGPI), 
a project that aims to identify useful glycobiomarkers for 
detecting life-style diseases by integrating proteomics with 
glycomics. In 2011, HPP formed Chromosome-based Hu-
man Proteome Project (Ch-HPP), a joint project that uses 
proteomics technology to determine the gene product of 
each chromosome. Ch-HPP brings together the best talents 
from HPP and HGP. Like the Chinese saying goes, “life 
does not discriminate for benevolence”. We should treat all 
‘omics’ as equally important. And lifeomics, which inte-
grates genomics and RNAomics with proteomics, gly-
comics and metabolomics, has taken shape and is now ready 
to take on any challenges. 
Looking back at the history of natural sciences, especial-
ly in life sciences, we can draw an analogy between the age 
of grand discoveries and nuclear fusion. We understand that 
only through fusion can we release large amounts of energy. 
However, to obtain enough energy to trigger the fusion 
process, we need nuclear fission. 
Therefore, HGP was not just a beginning. It was the fis-
sion point that triggered the development of various omics. 
Lifeomics, which encompasses all these omics, is set to 
achieve something big. To our knowledge, projects utilizing 
a similar research approach have only appeared twice in 
human history: once in the Manhattan project and once in 
the Apollo program. In both cases, the scientific discoveries 
made have had far-reaching impact on our society.  
With life come organic, as the biological world is the 
culmination (organization) of, for and over the physical 
world (from inorganic to organic to biological). With life 
also come human cognition, and this is the magic that con-
nects the biological and the physical world. Because of this, 
we trust that life science is going to be the epitome and as-
semble of all disciplines of natural sciences. Furthermore, 
lifeomics is the backbone for life science. Thus, it is going 
to be the rising star of natural sciences in the coming future.   
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